![](/img/cover-not-exists.png)
Commentary on Androgen receptor survival signaling is blocked by anti-{β}2-microglobulin monoclonal antibody via a MAPK/lipogenic pathway in human prostate cancer cells: Huang WC, Zhau HE, Chung LW, Uro-Oncology Research Program, Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA
Kenneth S. KoenemanVolume:
28
Year:
2010
Language:
english
DOI:
10.1016/j.urolonc.2010.03.006
File:
PDF, 90 KB
english, 2010